Regarding pathologic tumor and LN staging, we observed that relatives whose diagnoses of MTC/CCH were made after RET screening had smaller tumor dimensions than index patients (p < 0.05), although there was no significant difference in the frequency of LN involvement between the two groups (Figure 5, Table 4). This evidence concerns the gene RET and neoplasm.